Brian J. Dale

Brian J. Dale

Auto-generated profile, based on publicly available information

Brian J. Dale

School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2015 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
BDBrian J. Dale
Brian J. Dale
NCNoel Chan
Noel Chan
JEJohn W. Eikelboom
John W. Eikelboom

1 November 2014 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
BDB. J. Dale
B. J. Dale
JGJ. S. Ginsberg
J. S. Ginsberg
MJM. Johnston
M. Johnston
JHJ. Hirsh
J. Hirsh
JWJ. I. Weitz
J. I. Weitz
JEJ. W. Eikelboom
J. W. Eikelboom

16 December 2012 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
BDBrian Dale
Brian Dale
JEJohn W. Eikelboom
John W. Eikelboom
JWJeffrey I. Weitz
Jeffrey I. Weitz
EYEd Young
Ed Young
JPJeremy S. Paikin
Jeremy S. Paikin
JHJack Hirsh
Jack Hirsh

1 July 2014 in Thrombosis Research
Verified
Journal Article
Closed access
SRSusan E. Rodgers
Susan E. Rodgers
AWAmanda Wong
Amanda Wong
RGReanuga D. Gopal
Reanuga D. Gopal
BDBrian J. Dale
Brian J. Dale
EDElizabeth M. Duncan
Elizabeth M. Duncan
SMSimon J. McRae
Simon J. McRae

3 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CMCarmela Martini
Carmela Martini
ETEmma J. Thompson
Emma J. Thompson
SHStephanie R. Hyslop
Stephanie R. Hyslop
MCMichaelia P. Cockshell
Michaelia P. Cockshell
BDBrian J. Dale
Brian J. Dale
Claudine BonderClaudine Bonder
Claudine Bonder
Tumour vasculature supports the growth and progression of solid cancers with both angiogenesis (endothelial cell proliferation) and vasculogenic mimicry (VM, the formation of vascular structures by cancer cells themselves) predictors of poor patient outcomes. Increased circulating platelet counts also predict poor outcome for cancer patients but the influence of platelets on tumour vasculature is incompletely understood. Herein, we show with in vitro assays that platelets did not influence angiogenesis but did actively inhibit VM formation by cancer cell lines. Both platelet sized beads and the releasates from platelets were partially effective at inhibiting VM formation suggesting that direct contact maximises the effect. Platelets also promoted cancer cell invasion in vitro. B16F10 melanomas in Bcl-xPlt20/Plt20 thrombocytopenic mice showed a higher content of VM than their wildtype counterparts while angiogenesis did not differ. In a xenograft mouse model of breast cancer with low-dose aspirin to inactivate the platelets, the burden of MDA-MB-231-LM2 breast cancer cells was reduced and the gene expression profile of the cancer cells was altered; but no effect on tumour vasculature was observed. Taken together, this study provides new insights into the action of platelets on VM formation and their involvement in cancer progression.

1 October 2012 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
KAKyle A. Arsenault
Kyle A. Arsenault
JPJeremy S. Paikin
Jeremy S. Paikin
JHJack Hirsh
Jack Hirsh
BDBrian Dale
Brian Dale
RWRichard P. Whitlock
Richard P. Whitlock
JEJohn W. Eikelboom
John W. Eikelboom